{"id":"https://openalex.org/W2411001292","doi":null,"title":"Randomized phase II study comparing mitomycin, cisplatin plus doxifluridine with cisplatin plus doxifluridine in advanced unresectable gastric cancer.","display_name":"Randomized phase II study comparing mitomycin, cisplatin plus doxifluridine with cisplatin plus doxifluridine in advanced unresectable gastric cancer.","publication_year":2004,"publication_date":"2004-07-01","ids":{"openalex":"https://openalex.org/W2411001292","mag":"2411001292","pmid":"https://pubmed.ncbi.nlm.nih.gov/15330199"},"language":"en","primary_location":{"id":"pmid:15330199","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15330199","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Clinical Trial"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068425977","display_name":"Wasaburo Koizumi","orcid":"https://orcid.org/0000-0001-9972-1083","observed_orcids":["https://orcid.org/0000-0001-9972-1083"]},"institutions":[{"id":"https://openalex.org/I4405278910","display_name":"Tokyo Cooperative Oncology Group","ror":"https://ror.org/00rbsap34","country_code":"JP","type":"nonprofit","lineage":["https://openalex.org/I4405278910"]},{"id":"https://openalex.org/I64189623","display_name":"Kitasato University","ror":"https://ror.org/00f2txz25","country_code":"JP","type":"education","lineage":["https://openalex.org/I64189623"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Wasaburo Koizumi","raw_affiliation_strings":["The Tokyo Cooperative Oncology Group, Department of Internal Medicine, Kitasato University School of Medicine, 2-1-1 Asamozodai Sagamihara-shi, Kanagawa 228-8520, Japan. Koizumi@med.kitasato-u.ac.jp","The Tokyo Cooperative Oncology Group, Department of Internal Medicine, Kitasato University School of Medicine, 2-1-1 Asamozodai Sagamihara-shi, Kanagawa 228-8520, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Tokyo Cooperative Oncology Group, Department of Internal Medicine, Kitasato University School of Medicine, 2-1-1 Asamozodai Sagamihara-shi, Kanagawa 228-8520, Japan. Koizumi@med.kitasato-u.ac.jp","institution_ids":["https://openalex.org/I4405278910","https://openalex.org/I64189623"]},{"raw_affiliation_string":"The Tokyo Cooperative Oncology Group, Department of Internal Medicine, Kitasato University School of Medicine, 2-1-1 Asamozodai Sagamihara-shi, Kanagawa 228-8520, Japan","institution_ids":["https://openalex.org/I4405278910","https://openalex.org/I64189623"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113761916","display_name":"Yoshio Fukuyama","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yoshio Fukuyama","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111691526","display_name":"Takahiro Fukuda","orcid":"https://orcid.org/0009-0006-9490-4669","observed_orcids":["https://orcid.org/0009-0006-9490-4669"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Takahiro Fukuda","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017443386","display_name":"Toshikazu Akiya","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Toshikazu Akiya","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031178248","display_name":"Kouichi Hasegawa","orcid":"https://orcid.org/0000-0001-5947-5471","observed_orcids":["https://orcid.org/0000-0001-5947-5471"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kouichi Hasegawa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112079544","display_name":"Yasuaki Kojima","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yasuaki Kojima","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087861858","display_name":"Nobutsugu Ohno","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nobutsugu Ohno","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5103505712","display_name":"Minoru Kurihara","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Minoru Kurihara","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.9165,"has_fulltext":false,"cited_by_count":14,"citation_normalized_percentile":{"value":0.73884556,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"24","issue":"4","first_page":"2465","last_page":"70"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12064","display_name":"Intraperitoneal and Appendiceal Malignancies","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mitomycin-c","display_name":"mitomycin C","score":0.8740000128746033},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.9950000047683716},{"id":"https://openalex.org/keywords/doxifluridine","display_name":"doxifluridine","score":0.9929999709129333},{"id":"https://openalex.org/keywords/fluoropyrimidine","display_name":"fluoropyrimidine","score":0.8309999704360962},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.8009999990463257},{"id":"https://openalex.org/keywords/response-rate","display_name":"response rate","score":0.8769999742507935},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.6990000009536743}],"concepts":[{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.8500644564628601},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7172101736068726},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.6256206035614014},{"id":"https://openalex.org/C2777909004","wikidata":"https://www.wikidata.org/wiki/Q420207","display_name":"Capecitabine","level":4,"score":0.5927259922027588},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5076388120651245},{"id":"https://openalex.org/C2779338040","wikidata":"https://www.wikidata.org/wiki/Q19856779","display_name":"Mitomycin C","level":2,"score":0.47782090306282043},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4769405424594879},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4524194598197937},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3799884617328644},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.35270804166793823},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3322928547859192},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.3312298059463501},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.2693633437156677},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.07291889190673828}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005467","descriptor_name":"Floxuridine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005467","descriptor_name":"Floxuridine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013274","descriptor_name":"Stomach Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016685","descriptor_name":"Mitomycin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016685","descriptor_name":"Mitomycin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:15330199","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15330199","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Clinical Trial"},{"id":"mag:2411001292","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15330199","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1990178858","https://openalex.org/W2414579301","https://openalex.org/W2243544644","https://openalex.org/W1982559524","https://openalex.org/W1970708042","https://openalex.org/W1995921702","https://openalex.org/W2586053209","https://openalex.org/W2004136523","https://openalex.org/W2020690576","https://openalex.org/W1993576997"],"abstract_inverted_index":{"UNLABELLED:":[0],"Various":[1],"chemotherapies":[2],"have":[3],"been":[4],"used":[5],"to":[6,92,95,98,102,115],"treat":[7],"inoperable":[8],"gastric":[9,60],"cancer.":[10,61],"Most":[11],"combination":[12],"therapies":[13],"include":[14],"cisplatin":[15],"(CDDP)":[16],"and":[17,36,46,84,100,107,147,169],"fluoropyrimidine":[18],"(5-FUs),":[19],"which":[20,41],"are":[21],"thought":[22],"of":[23,50],"as":[24,166],"key":[25],"drugs.":[26],"In":[27,154],"the":[28],"present":[29],"study,":[30],"we":[31,173],"randomly":[32],"compared":[33],"mitomycin":[34],"(MMC)":[35],"CDDP":[37,54,65],"plus":[38,55],"doxifluridine":[39],"(5'-DFUR),":[40],"is":[42],"an":[43,47],"oral":[44,85],"5-FU":[45],"intermediate":[48],"metabolite":[49],"capecitabine":[51],"(Xeloda),":[52],"with":[53,182],"5'-DFUR":[56,86],"in":[57,128,133,144,150],"advanced":[58],"unresectable":[59],"Regimen":[62,111,129,134,145,151,155],"A":[63,117,146],"was":[64,113,124,141,161],"(70":[66],"mg/m2,":[67,78,88],"by":[68],"2-hour":[69],"intravenous":[70],"drip":[71],"infusion":[72],"on":[73,81,89],"day":[74,82],"1),":[75],"MMC":[76],"(7":[77],"injected":[79],"intravenously":[80],"2),":[83],"(1200":[87],"days":[90,105,109,143,149],"4":[91,108],"7,":[93],"11":[94],"14,":[96],"18":[97],"21":[99],"25":[101],"28;":[103],"3":[104],"rest":[106],"administration).":[110],"B":[112,135,152],"identical":[114],"regimen":[116],"without":[118],"MMC.":[119],"RESULTS:":[120],"The":[121,137],"response":[122,167],"rate":[123,168],"25.0%":[125],"(8/32":[126],"patients)":[127],"A,":[130,156],"17.2%":[131],"(5/29)":[132],"(p=0.541).":[136],"median":[138],"survival":[139],"time":[140],"241":[142],"179":[148],"(p=0.498).":[153],"although":[157],"no":[158],"significant":[159],"difference":[160],"observed,":[162],"end":[163],"points":[164],"such":[165],"suvival":[170],"improved.":[171],"Thus,":[172],"concluded":[174],"that":[175],"a":[176],"randomized":[177],"controlled":[178],"phase":[179],"III":[180],"study":[181],"more":[183],"subjects":[184],"should":[185],"be":[186],"conducted.":[187]},"counts_by_year":[{"year":2019,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}